EichorEICHOR
Condition: Gastrooesophageal Cancer Synced from ClinicalTrials.gov · August 08, 2026

Recruiting studies: Gastrooesophageal Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastr
Phase N/A · 4 location(s) · M.D. Anderson Cancer Center · NCT05205343Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic C
Phase 2 · 21 location(s) · UNICANCER · NCT06245356Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Pa
Phase 2 · 2 location(s) · Shanghai Zhongshan Hospital · NCT06468280Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standa
Phase 1 · 1 location(s) · Henry Ford Health System · NCT06065371sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
Phase 2 · 6 location(s) · Rutgers, The State University of New Jersey · NCT05332002Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer
Phase N/A · 1 location(s) · Karolinska Institutet · NCT06687291A Phase 1/1b Study of IAM1363 in HER2 Cancers
Phase 1 · 53 location(s) · Iambic Therapeutics, Inc · NCT06253871Developing ctDNA Guided Adjuvant Therapy for Gastrooesophageal Cancer
Phase 2 · 14 location(s) · University of Southampton · NCT05965479Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer
NA · 1 location(s) · The Second Hospital of Shandong University · NCT04688801GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)
Phase N/A · 1 location(s) · Centre Leon Berard · NCT05644431A Phase 1 Study of the Safety and Tolerability of CTX-10726
Phase 1 · 5 location(s) · Compass Therapeutics · NCT07419841A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
Phase 1/Phase 2 · 16 location(s) · Bolt Biotherapeutics, Inc. · NCT06921837Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Phase 3 · 15 location(s) · SOFIE · NCT07217704Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer
Phase 2/Phase 3 · 2 location(s) · Ukrainian Society of Clinical Oncology · NCT06028737BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer
Phase 2 · 1 location(s) · Barbara Malene Fischer · NCT07629609A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Phase 2 · 28 location(s) · Jazz Pharmaceuticals · NCT06695845A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 17 location(s) · IDEAYA Biosciences · NCT07277413Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastri
Phase 2 · 100 location(s) · AstraZeneca · NCT04379596Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 6 location(s) · ModeX Therapeutics, An OPKO Health Company · NCT06239194A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction A
Phase 1 · 3 location(s) · Dong-A ST Co., Ltd. · NCT07481357A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 3 location(s) · Arvinas Inc. · NCT07749586Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointes
Phase 1/Phase 2 · 2 location(s) · Anwaar Saeed · NCT03539822CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1
Phase N/A · 2 location(s) · Heinrich-Heine University, Duesseldorf · NCT04455282Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer
NA · 2 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06497569Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease
Phase 2 · 1 location(s) · Gruppo Oncologico del Nord-Ovest · NCT06253650A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
Phase 2 · 1 location(s) · National University Hospital, Singapore · NCT06422403The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)
NA · 22 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06138223PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
Phase 2 · 1 location(s) · Medical College of Wisconsin · NCT06906887Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma
NA · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06644352Sample Collection for Ongoing Research and Product Evaluation Study
Phase N/A · 1 location(s) · Natera, Inc. · NCT07318051
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.